Time-Course Analysis of Protein and Lipid Oxidation in the Brains of Yac128 Huntington's Disease Transgenic Mice

被引:14
|
作者
Brocardo, Patricia S. [1 ,2 ,3 ]
McGinnis, Eric [1 ,2 ]
Christie, Brian R. [1 ,2 ,4 ,5 ,6 ]
Gil-Mohapel, Joana [1 ,2 ]
机构
[1] Univ Victoria, Div Med Sci, Victoria, BC, Canada
[2] Univ Victoria, UBC Isl Med Program, Victoria, BC, Canada
[3] Univ Fed Santa Catarina, Dept Morphol Sci, Florianopolis, SC, Brazil
[4] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Program Neurosci, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
基金
加拿大健康研究院; 加拿大创新基金会; 加拿大自然科学与工程研究理事会;
关键词
AGE-RELATED INCREASE; MOUSE MODEL; COENZYME Q(10); NEUROLOGICAL PHENOTYPE; MUTANT HUNTINGTIN; NEURONAL LOSS; DAMAGE; STRESS; DYSFUNCTION; NEURODEGENERATION;
D O I
10.1089/rej.2015.1736
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Huntington's disease (HD) is caused by an expansion of cytosine-adenine-guanine (CAG) repeats within the coding region of the HD gene, which expresses the protein huntingtin and is characterized by selective degeneration of specific neuronal populations, mainly in the striatum and the cortex. The mechanisms that account for this selective neuronal death are multifaceted, but oxidative stress might play an important role in this process. To determine whether changes in the intracellular redox state will result in oxidative damage to cellular macromolecules with disease progression, we analyzed levels of lipid peroxidation (with the thiobarbituric acid reactive substances [TBARS] assay) and protein carbonyl formation (using the 2,4-dinitrophenylhydrazine reaction) in the cerebellum, cerebral cortex, prefrontal cortex, striatum, and hippocampus of the YAC128 HD mouse model at 3, 6, and 12 months of age. With the exception of a transient increase in protein carbonyl levels in the YAC128 prefrontal cortex at 6 months of age, levels of lipid peroxidation and protein oxidation were not significantly different between YAC128 mice and their age-matched wild-type counterparts in any of the brain regions analyzed up to 12 months of age. However, age-related increases in oxidative stress were observed in various brain regions. These results suggest that lipid and protein oxidative damage is not a major contributor to neurodegeneration in the YAC128 brain up to 12 months of age.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 50 条
  • [21] Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice
    Placido, Evelini
    Gomes Welter, Priscilla
    Wink, Ana
    Karasiak, Gabriela Duarte
    Outeiro, Tiago Fleming
    Dafre, Alcir Luiz
    Gil-Mohapel, Joana
    Brocardo, Patricia S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [22] Huntington mutation produces age-dependent alterations in striatal excitation in YAC128 transgenic mice
    Bamford, N. S.
    Joyce, J. A.
    [J]. ANNALS OF NEUROLOGY, 2008, 64 : S115 - S115
  • [23] Mutant Allele Knockdown in the YAC128 Transgenic Mouse Model of Huntington's Disease Using an Artificial Transcription Factor
    Deng, P.
    Halmai, J. A. N. M.
    Sandoval, I. M.
    Manfredsson, F. P.
    Segal, D. J.
    Nolta, J. A.
    Fink, K. D.
    [J]. CELL TRANSPLANTATION, 2018, 27 (04) : 688 - 689
  • [24] Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
    Garcia-Miralles, Marta
    Geva, Michal
    Tan, Jing Ying
    Yusof, Nur Amirah Binte Mohammad
    Cha, Yoonjeong
    Kusko, Rebecca
    Tan, Liang Juin
    Xu, Xiaohong
    Grossman, Iris
    Orbach, Aric
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    [J]. JCI INSIGHT, 2017, 2 (23)
  • [25] Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease
    Lerch, Jason P.
    Carroll, Jeffrey B.
    Dorr, Adrienne
    Spring, Shoshana
    Evans, Alan C.
    Hayden, Michael R.
    Sled, John G.
    Henkelman, R. Mark
    [J]. NEUROIMAGE, 2008, 41 (02) : 243 - 251
  • [26] Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington's Disease
    Nascimento-Castro, Cristine De Paula
    Winkelmann-Duarte, Elisa C.
    Mancini, Gianni
    Welter, Priscilla Gomes
    Placido, Evelini
    Farina, Marcelo
    Gil-Mohapel, Joana
    Rodrigues, Ana Lucia S.
    de Bem, Andreza Fabro
    Brocardo, Patricia S.
    [J]. BIOMEDICINES, 2022, 10 (06)
  • [27] Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
    Van Raamsdonk, JM
    Pearson, J
    Slow, EJ
    Hossain, SM
    Leavitt, BR
    Hayden, MR
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (16): : 4169 - 4180
  • [28] Manganese Differentially Regulates Dopaminergic Dynamics and Behavior in the YAC128 Mouse Model of Huntington's Disease
    Wilcox, Jordyn
    Consoli, David
    Debbiche, Ines
    Calipari, Erin
    Bowman, Aaron
    Harrison, Fiona
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2020, 159 : S83 - S84
  • [29] Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice
    Wong, Bibiana K. Y.
    Ehrnhoefer, Dagmar E.
    Graham, Rona K.
    Martin, Dale D. O.
    Ladha, Safia
    Uribe, Valeria
    Stanek, Lisa M.
    Franciosi, Sonia
    Qiu, Xiaofan
    Deng, Yu
    Kovalik, Vlad
    Zhang, Weining
    Pouladi, Mahmoud A.
    Shihabuddin, Lamya S.
    Hayden, Michael R.
    [J]. NEUROBIOLOGY OF DISEASE, 2015, 76 : 24 - 36
  • [30] Huntington Disease Gene Expression Signatures in Blood Compared to Brain of YAC128 Mice as Candidates for Monitoring of Pathology
    Kuijper, Elsa C.
    Toonen, Lodewijk J. A.
    Overzier, Maurice
    Tsonaka, Roula
    Hettne, Kristina
    Roos, Marco
    Van Roon-Mom, Willeke M. C.
    Mina, Eleni
    [J]. MOLECULAR NEUROBIOLOGY, 2022, 59 (04) : 2532 - 2551